Connection

W. Garvey to Humans

Back to Details
This is a "connection" page, showing publications W. Garvey has written about Humans.
W. Garvey
Connection Strength
2.274
Humans
  1. Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program. Popul Health Manag. 2023 02; 26(1):72-82.
    View in: PubMed
    Score: 0.032
  2. Two-year effect of semaglutide 2.4?mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring). 2023 03; 31(3):703-715.
    View in: PubMed
    Score: 0.032
  3. Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020. J Med Econ. 2023 Jan-Dec; 26(1):376-385.
    View in: PubMed
    Score: 0.032
  4. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022 10; 28(10):2083-2091.
    View in: PubMed
    Score: 0.032
  5. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study. J Manag Care Spec Pharm. 2022 Oct; 28(10):1066-1079.
    View in: PubMed
    Score: 0.031
  6. A health-education intervention to improve outcomes for children with emotional and behavioural difficulties: protocol for a pilot cluster randomised controlled trial. BMJ Open. 2022 06 23; 12(6):e060440.
    View in: PubMed
    Score: 0.031
  7. Examining the evidence for weight management in individuals with type 2 diabetes. Diabetes Obes Metab. 2022 08; 24(8):1411-1422.
    View in: PubMed
    Score: 0.031
  8. Associations between cardiometabolic disease severity, social determinants of health (SDoH), and poor COVID-19 outcomes. Obesity (Silver Spring). 2022 07; 30(7):1483-1494.
    View in: PubMed
    Score: 0.031
  9. New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications. J Clin Endocrinol Metab. 2022 03 24; 107(4):e1339-e1347.
    View in: PubMed
    Score: 0.031
  10. Is Obesity or Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second-Generation Medications. Endocr Pract. 2022 Feb; 28(2):214-222.
    View in: PubMed
    Score: 0.030
  11. Long-term health benefits of intensive lifestyle intervention in the Look AHEAD study. Obesity (Silver Spring). 2021 08; 29(8):1242-1243.
    View in: PubMed
    Score: 0.029
  12. Arterial Stiffness: Comment on the Article by Pavloska et?al. Endocr Pract. 2021 06; 27(6):640-641.
    View in: PubMed
    Score: 0.029
  13. Building Successful Models in Primary Care to Improve the Management of Adult Patients with Obesity. Popul Health Manag. 2021 10; 24(5):548-559.
    View in: PubMed
    Score: 0.029
  14. Diagnosing Obesity as a First Step to Weight Loss: An Observational Study. Obesity (Silver Spring). 2020 12; 28(12):2305-2309.
    View in: PubMed
    Score: 0.028
  15. Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study. PLoS Med. 2020 08; 17(8):e1003232.
    View in: PubMed
    Score: 0.027
  16. Covid-19 & Obesity: Beyond Bmi. Endocr Pract. 2020 Aug; 26(8):923-925.
    View in: PubMed
    Score: 0.027
  17. Response to "The Future of Obesity Diagnostic Coding". Obesity (Silver Spring). 2020 07; 28(7):1169-1170.
    View in: PubMed
    Score: 0.027
  18. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care. 2020 05; 43(5):1085-1093.
    View in: PubMed
    Score: 0.026
  19. Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity. Obesity (Silver Spring). 2020 03; 28(3):484-492.
    View in: PubMed
    Score: 0.026
  20. Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 02 11; 75(5):525-538.
    View in: PubMed
    Score: 0.026
  21. Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 02 11; 75(5):539-555.
    View in: PubMed
    Score: 0.026
  22. Core Principles, Treatment Standards, and Provider Competencies for the Care of Patients with Obesity. Obesity (Silver Spring). 2019 07; 27(7):1045-1047.
    View in: PubMed
    Score: 0.025
  23. COMMENTARY FROM THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS ON THE U.S. PREVENTIVE SERVICES TASK FORCE RECOMMANDATIONS REGARDING WEIGHT LOSS INTERVENTIONS. Endocr Pract. 2019 04; 25(4):394-395.
    View in: PubMed
    Score: 0.025
  24. Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study. Diabetes Care. 2019 06; 42(6):1104-1111.
    View in: PubMed
    Score: 0.025
  25. DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT. Endocr Pract. 2018 Nov; 24(11):995-1011.
    View in: PubMed
    Score: 0.024
  26. Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes. Metabolism. 2018 08; 85:32-37.
    View in: PubMed
    Score: 0.023
  27. Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans. Metab Syndr Relat Disord. 2018 03; 16(2):82-89.
    View in: PubMed
    Score: 0.023
  28. Leptin, An Adipokine With Central Importance in the Global Obesity Problem. Glob Heart. 2018 06; 13(2):113-127.
    View in: PubMed
    Score: 0.023
  29. Obesity: Obesity and cardiometabolic disease - more than meets the eye. Nat Rev Endocrinol. 2017 10; 13(10):566-568.
    View in: PubMed
    Score: 0.022
  30. Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release. Diabetes Care. 2017 07; 40(7):856-862.
    View in: PubMed
    Score: 0.022
  31. Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201. Diabetes Care. 2017 02; 40(2):e21-e22.
    View in: PubMed
    Score: 0.021
  32. ADIPOSITY-BASED CHRONIC DISEASE AS A NEW DIAGNOSTIC TERM: THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT. Endocr Pract. 2017 Mar; 23(3):372-378.
    View in: PubMed
    Score: 0.021
  33. Ablation of the Duodenal Mucosa as a Strategy for Glycemic Control in Type 2 Diabetes: Role of Nutrient Signaling or Simple Weight Loss. Diabetes Care. 2016 12; 39(12):2108-2110.
    View in: PubMed
    Score: 0.021
  34. The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice. J Am Coll Cardiol. 2016 10 18; 68(16):1785-1803.
    View in: PubMed
    Score: 0.021
  35. Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders. Postgrad Med. 2016 Aug; 128(6):591-7.
    View in: PubMed
    Score: 0.021
  36. Trends in Cardiovascular Health Metrics in Obese Adults: National Health and Nutrition Examination Survey (NHANES), 1988-2014. J Am Heart Assoc. 2016 07 13; 5(7).
    View in: PubMed
    Score: 0.021
  37. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines. Endocr Pract. 2016 07; 22(7):842-84.
    View in: PubMed
    Score: 0.021
  38. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract. 2016 Jul; 22 Suppl 3:1-203.
    View in: PubMed
    Score: 0.020
  39. Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet-Induced Insulin Resistance. Diabetes. 2016 08; 65(8):2380-91.
    View in: PubMed
    Score: 0.020
  40. Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: Stability of metabolic health status in adults. Obesity (Silver Spring). 2016 Feb; 24(2):516-25.
    View in: PubMed
    Score: 0.020
  41. Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and Inflammation. Metab Syndr Relat Disord. 2016 Feb; 14(1):7-15.
    View in: PubMed
    Score: 0.020
  42. Weight maintenance: challenges, tools and strategies for primary care physicians. Obes Rev. 2016 Jan; 17(1):81-93.
    View in: PubMed
    Score: 0.020
  43. Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes. J Clin Endocrinol Metab. 2015 Oct; 100(10):3871-7.
    View in: PubMed
    Score: 0.019
  44. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Curr Obes Rep. 2015 Jun; 4(2):287-302.
    View in: PubMed
    Score: 0.019
  45. The conundrum of whole foods versus macronutrient composition in assessing effects on insulin sensitivity. Am J Clin Nutr. 2015 Jun; 101(6):1109-10.
    View in: PubMed
    Score: 0.019
  46. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care. 2014 Dec; 37(12):3309-16.
    View in: PubMed
    Score: 0.018
  47. Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord. 2014 Jun; 12(5):258-68.
    View in: PubMed
    Score: 0.017
  48. BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. Diabetes. 2014 Feb; 63(2):791-800.
    View in: PubMed
    Score: 0.017
  49. Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care. 2014 Apr; 37(4):912-21.
    View in: PubMed
    Score: 0.017
  50. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013 Oct; 20(5):377-88.
    View in: PubMed
    Score: 0.017
  51. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity (Silver Spring). 2014 Jan; 22(1):110-8.
    View in: PubMed
    Score: 0.017
  52. New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach. Endocr Pract. 2013 Sep-Oct; 19(5):864-74.
    View in: PubMed
    Score: 0.017
  53. Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management. Expert Opin Drug Saf. 2013 Sep; 12(5):741-56.
    View in: PubMed
    Score: 0.017
  54. New options for the treatment of obesity and type 2 diabetes mellitus (narrative review). J Diabetes Complications. 2013 Sep-Oct; 27(5):508-18.
    View in: PubMed
    Score: 0.017
  55. Type 2 diabetes with partial lipodystrophy of the limbs: a new lipodystrophy phenotype. Diabetes Care. 2013 Aug; 36(8):2247-53.
    View in: PubMed
    Score: 0.016
  56. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care. 2013 Apr; 36(4):845-53.
    View in: PubMed
    Score: 0.016
  57. Prostaglandin A2 enhances cellular insulin sensitivity via a mechanism that involves the orphan nuclear receptor NR4A3. Horm Metab Res. 2013 Mar; 45(3):213-20.
    View in: PubMed
    Score: 0.016
  58. American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine. Endocr Pract. 2012 Sep-Oct; 18(5):642-8.
    View in: PubMed
    Score: 0.016
  59. Skeletal muscle lipid peroxidation and insulin resistance in humans. J Clin Endocrinol Metab. 2012 Jul; 97(7):E1182-6.
    View in: PubMed
    Score: 0.015
  60. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012 Feb; 95(2):297-308.
    View in: PubMed
    Score: 0.015
  61. Intramyocellular lipid and insulin resistance: differential relationships in European and African Americans. Obesity (Silver Spring). 2011 Jul; 19(7):1469-75.
    View in: PubMed
    Score: 0.014
  62. Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioning. J Appl Physiol (1985). 2011 Mar; 110(3):746-55.
    View in: PubMed
    Score: 0.014
  63. Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance. Am J Physiol Endocrinol Metab. 2010 Mar; 298(3):E565-76.
    View in: PubMed
    Score: 0.013
  64. The genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: the Sea Islands Genetic African American Registry (Project SuGAR). J Lipid Res. 2010 Mar; 51(3):586-97.
    View in: PubMed
    Score: 0.013
  65. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr. 2009 Jun; 139(6):1073-81.
    View in: PubMed
    Score: 0.012
  66. Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am. 2008 Dec; 37(4):841-56.
    View in: PubMed
    Score: 0.012
  67. Genome-wide linkage scan in Gullah-speaking African American families with type 2 diabetes: the Sea Islands Genetic African American Registry (Project SuGAR). Diabetes. 2009 Jan; 58(1):260-7.
    View in: PubMed
    Score: 0.012
  68. Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans. Obesity (Silver Spring). 2008 Dec; 16(12):2616-23.
    View in: PubMed
    Score: 0.012
  69. Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. Metabolism. 2008 Jan; 57(1):1-8.
    View in: PubMed
    Score: 0.011
  70. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol. 2007 Jun; 18(3):263-70.
    View in: PubMed
    Score: 0.011
  71. The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle. Endocrine. 2007 Feb; 31(1):5-17.
    View in: PubMed
    Score: 0.011
  72. Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women. Diabetes. 2006 Dec; 55(12):3630-4.
    View in: PubMed
    Score: 0.011
  73. Uncoupling protein 3 and human metabolism. J Clin Endocrinol Metab. 2006 Apr; 91(4):1226-8.
    View in: PubMed
    Score: 0.010
  74. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006 Jan; 55(1):249-59.
    View in: PubMed
    Score: 0.010
  75. Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis. 2006 Sep; 188(1):102-11.
    View in: PubMed
    Score: 0.010
  76. Mitochondrial DNA (mtDNA) haplotypes reveal maternal population genetic affinities of Sea Island Gullah-speaking African Americans. Am J Phys Anthropol. 2005 Aug; 127(4):427-38.
    View in: PubMed
    Score: 0.010
  77. Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach. J Clin Endocrinol Metab. 2004 Sep; 89(9):4197-205.
    View in: PubMed
    Score: 0.009
  78. Estimation of resting energy expenditure considering effects of race and diabetes status. Diabetes Care. 2004 Jun; 27(6):1405-11.
    View in: PubMed
    Score: 0.009
  79. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004 Apr; 27(4):978-83.
    View in: PubMed
    Score: 0.009
  80. Individual differences in the response to ingested nutrients. Nutrition. 2004 Jan; 20(1):1.
    View in: PubMed
    Score: 0.009
  81. Role of UCP2 and UCP3 in nutrition and obesity. Nutrition. 2004 Jan; 20(1):139-44.
    View in: PubMed
    Score: 0.009
  82. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):182-90.
    View in: PubMed
    Score: 0.009
  83. Three novel mtDNA restriction site polymorphisms allow exploration of population affinities of African Americans. Hum Biol. 2003 Apr; 75(2):147-61.
    View in: PubMed
    Score: 0.008
  84. Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network. J Am Heart Assoc. 2023 Feb 21; 12(4):e027693.
    View in: PubMed
    Score: 0.008
  85. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003 Feb; 52(2):453-62.
    View in: PubMed
    Score: 0.008
  86. The role of uncoupling protein 3 in human physiology. J Clin Invest. 2003 Feb; 111(4):438-41.
    View in: PubMed
    Score: 0.008
  87. Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes. Diabetes Res Clin Pract. 2002 Nov; 58(2):87-96.
    View in: PubMed
    Score: 0.008
  88. Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes Obes Metab. 2023 02; 25(2):468-478.
    View in: PubMed
    Score: 0.008
  89. Household disorder and blood pressure in mother-child dyads: A brief report. J Fam Psychol. 2023 Mar; 37(2):256-261.
    View in: PubMed
    Score: 0.008
  90. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr Pract. 2022 Oct; 28(10):923-1049.
    View in: PubMed
    Score: 0.008
  91. Race Versus Social Determinants of Health in COVID-19 Hospitalization Prediction. Am J Prev Med. 2022 07; 63(1 Suppl 1):S103-S108.
    View in: PubMed
    Score: 0.008
  92. French-fried potato consumption and energy balance: a randomized controlled trial. Am J Clin Nutr. 2022 06 07; 115(6):1626-1636.
    View in: PubMed
    Score: 0.008
  93. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022 May; 28(5):528-562.
    View in: PubMed
    Score: 0.008
  94. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):138-150.
    View in: PubMed
    Score: 0.008
  95. Case presentation and panel discussion: Cardiometabolic risk mitigation. JPEN J Parenter Enteral Nutr. 2021 11; 45(S2):93-99.
    View in: PubMed
    Score: 0.007
  96. Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking. J Clin Endocrinol Metab. 2001 Nov; 86(11):5450-6.
    View in: PubMed
    Score: 0.007
  97. Sex and race contribute to variation in mitochondrial function and insulin sensitivity. Physiol Rep. 2021 10; 9(19):e15049.
    View in: PubMed
    Score: 0.007
  98. Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity-Reply. JAMA. 2021 09 28; 326(12):1214-1215.
    View in: PubMed
    Score: 0.007
  99. Serum urate and cardiovascular events in the DCCT/EDIC study. Sci Rep. 2021 07 09; 11(1):14182.
    View in: PubMed
    Score: 0.007
  100. Genetic landscape of Gullah African Americans. Am J Phys Anthropol. 2021 08; 175(4):905-919.
    View in: PubMed
    Score: 0.007
  101. Tribbles Homolog 3 Mediates the Development and Progression of Diabetic Retinopathy. Diabetes. 2021 08; 70(8):1738-1753.
    View in: PubMed
    Score: 0.007
  102. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021 04 13; 325(14):1403-1413.
    View in: PubMed
    Score: 0.007
  103. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women. Am J Physiol Endocrinol Metab. 2021 05 01; 320(5):E864-E873.
    View in: PubMed
    Score: 0.007
  104. Reduced plasma leptin concentrations in bulimia nervosa. Psychoneuroendocrinology. 2000 Oct; 25(7):649-58.
    View in: PubMed
    Score: 0.007
  105. Impact of a weight loss and fitness intervention on exercise-associated plasma oxylipin patterns in obese, insulin-resistant, sedentary women. Physiol Rep. 2020 09; 8(17):e14547.
    View in: PubMed
    Score: 0.007
  106. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity (Silver Spring). 2020 06; 28(6):1050-1061.
    View in: PubMed
    Score: 0.007
  107. Race affects the association of obesity measures with insulin sensitivity. Am J Clin Nutr. 2020 03 01; 111(3):515-525.
    View in: PubMed
    Score: 0.007
  108. Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. Int J Obes (Lond). 2020 05; 44(5):990-998.
    View in: PubMed
    Score: 0.007
  109. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY. Endocr Pract. 2020 01; 26(1):107-139.
    View in: PubMed
    Score: 0.007
  110. CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY. Endocr Pract. 2019 Dec; 25(12):1346-1359.
    View in: PubMed
    Score: 0.006
  111. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020 Feb; 16(2):175-247.
    View in: PubMed
    Score: 0.006
  112. Exercise plasma metabolomics and xenometabolomics in obese, sedentary, insulin-resistant women: impact of a fitness and weight loss intervention. Am J Physiol Endocrinol Metab. 2019 12 01; 317(6):E999-E1014.
    View in: PubMed
    Score: 0.006
  113. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D. J Lipid Res. 2019 08; 60(8):1432-1439.
    View in: PubMed
    Score: 0.006
  114. Aberrant DNA sequence pattern caused by a heterozygosity. Biotechniques. 1999 Apr; 26(4):604-6.
    View in: PubMed
    Score: 0.006
  115. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY. Endocr Pract. 2019 01; 25(1):69-100.
    View in: PubMed
    Score: 0.006
  116. Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes. 1998 Dec; 47(12):1935-40.
    View in: PubMed
    Score: 0.006
  117. Cloning of Rab GTPases expressed in human skeletal muscle: studies in insulin-resistant subjects. Horm Metab Res. 1998 Nov; 30(11):656-62.
    View in: PubMed
    Score: 0.006
  118. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest. 1998 Oct 01; 102(7):1345-51.
    View in: PubMed
    Score: 0.006
  119. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am J Med. 1998 Oct; 105(4):331-45.
    View in: PubMed
    Score: 0.006
  120. Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband. J Lipid Res. 1998 Sep; 39(9):1870-6.
    View in: PubMed
    Score: 0.006
  121. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest. 1998 Jun 01; 101(11):2377-86.
    View in: PubMed
    Score: 0.006
  122. Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes. 1998 Apr; 47(4):685-7.
    View in: PubMed
    Score: 0.006
  123. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D. J Lipid Res. 2018 05; 59(5):872-883.
    View in: PubMed
    Score: 0.006
  124. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis. J Dermatol Sci. 2018 Jun; 90(3):343-356.
    View in: PubMed
    Score: 0.006
  125. Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings After 12-Week Treatment: A Randomized Substudy. Obesity (Silver Spring). 2018 02; 26(2):332-339.
    View in: PubMed
    Score: 0.006
  126. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY. Endocr Pract. 2018 01; 24(1):91-120.
    View in: PubMed
    Score: 0.006
  127. Clinical implications of the insulin resistance syndrome. Clin Cornerstone. 1998; 1(3):13-28.
    View in: PubMed
    Score: 0.006
  128. APPLICATION OF THE AACE/ACE ADVANCED FRAMEWORK FOR THE DIAGNOSIS OF OBESITY AND CARDIOMETABOLIC DISEASE STAGING IN A GENERAL POPULATION FROM 3 REGIONS OF VENEZUELA: THE VEMSOLS STUDY RESULTS. Endocr Pract. 2018 Jan; 24(1):6-13.
    View in: PubMed
    Score: 0.006
  129. Exercise in transgenic mice overexpressing GLUT4 glucose transporters: effects on substrate metabolism and glycogen regulation. Metabolism. 1997 Nov; 46(11):1349-57.
    View in: PubMed
    Score: 0.006
  130. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 2017 Sep; 14(9):e1002383.
    View in: PubMed
    Score: 0.006
  131. Gestational diabetes mellitus and gene mutations which affect insulin secretion. Diabetes Res Clin Pract. 1997 Jun; 36(3):135-41.
    View in: PubMed
    Score: 0.005
  132. Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study. Obesity (Silver Spring). 2017 05; 25(5):857-865.
    View in: PubMed
    Score: 0.005
  133. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab. 1997 Apr; 82(4):1293-300.
    View in: PubMed
    Score: 0.005
  134. Pharmacotherapy for Weight Management in the VHA. J Gen Intern Med. 2017 Apr; 32(Suppl 1):70-73.
    View in: PubMed
    Score: 0.005
  135. Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition. Diabetes. 1997 Mar; 46(3):444-50.
    View in: PubMed
    Score: 0.005
  136. Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
    View in: PubMed
    Score: 0.005
  137. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. Endocr Pract. 2017 02; 23(2):207-238.
    View in: PubMed
    Score: 0.005
  138. Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress. FASEB J. 2017 04; 31(4):1608-1619.
    View in: PubMed
    Score: 0.005
  139. Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons. Exp Physiol. 2017 01 01; 102(1):48-69.
    View in: PubMed
    Score: 0.005
  140. EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS. Endocr Pract. 2016 11; 22(11):1277-1287.
    View in: PubMed
    Score: 0.005
  141. TRANSCULTURALIZATION RECOMMENDATIONS FOR DEVELOPING LATIN AMERICAN CLINICAL PRACTICE ALGORITHMS IN ENDOCRINOLOGY--PROCEEDINGS OF THE 2015 PAN-AMERICAN WORKSHOP BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY. Endocr Pract. 2016 Apr; 22(4):476-501.
    View in: PubMed
    Score: 0.005
  142. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. Endocr Pract. 2016 Jan; 22(1):84-113.
    View in: PubMed
    Score: 0.005
  143. The effects of brefeldin A on the glucose transport system in rat adipocytes. Implications regarding the intracellular locus of insulin-sensitive Glut4. J Biol Chem. 1995 Dec 15; 270(50):30199-204.
    View in: PubMed
    Score: 0.005
  144. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY. Endocr Pract. 2015 Dec; 21(12):1403-14.
    View in: PubMed
    Score: 0.005
  145. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis. 2016 Jan; 244:93-100.
    View in: PubMed
    Score: 0.005
  146. AACE response to a candid discussion of obesity. Am J Med. 2015 Oct; 128(10):e57.
    View in: PubMed
    Score: 0.005
  147. Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles. J Clin Endocrinol Metab. 1995 Aug; 80(8):2437-46.
    View in: PubMed
    Score: 0.005
  148. Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care. 2015 Aug; 38(8):1567-82.
    View in: PubMed
    Score: 0.005
  149. Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies. Obesity (Silver Spring). 2015 Jul; 23 Suppl 2:S1-S26.
    View in: PubMed
    Score: 0.005
  150. AACE/ACE comprehensive diabetes management algorithm 2015. Endocr Pract. 2015 Apr; 21(4):438-47.
    View in: PubMed
    Score: 0.005
  151. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY. Endocr Pract. 2015 Apr; 21(4):413-37.
    View in: PubMed
    Score: 0.005
  152. Cardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: project SuGAR. South Med J. 2014 Oct; 107(10):607-14.
    View in: PubMed
    Score: 0.005
  153. Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study. Atherosclerosis. 2014 Sep; 236(1):188-195.
    View in: PubMed
    Score: 0.004
  154. Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. Metab Syndr Relat Disord. 2014 Oct; 12(8):422-9.
    View in: PubMed
    Score: 0.004
  155. Glucose transporter proteins and insulin sensitivity in humans. Braz J Med Biol Res. 1994 Apr; 27(4):933-9.
    View in: PubMed
    Score: 0.004
  156. Improved metabolic health alters host metabolism in parallel with changes in systemic xeno-metabolites of gut origin. PLoS One. 2014; 9(1):e84260.
    View in: PubMed
    Score: 0.004
  157. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters. Diabetes. 1993 Dec; 42(12):1773-85.
    View in: PubMed
    Score: 0.004
  158. Cellular insulin action and insulin resistance. Baillieres Clin Endocrinol Metab. 1993 Oct; 7(4):785-873.
    View in: PubMed
    Score: 0.004
  159. Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet. 2013; 9(8):e1003681.
    View in: PubMed
    Score: 0.004
  160. Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. J Diabetes Complications. 2013 Sep-Oct; 27(5):447-53.
    View in: PubMed
    Score: 0.004
  161. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract. 2013 May-Jun; 19(3):536-57.
    View in: PubMed
    Score: 0.004
  162. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet. 2013 Jun; 45(6):690-6.
    View in: PubMed
    Score: 0.004
  163. Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis. 2013 May; 228(1):124-35.
    View in: PubMed
    Score: 0.004
  164. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract. 2013 Mar-Apr; 19(2):337-72.
    View in: PubMed
    Score: 0.004
  165. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013 Mar; 21 Suppl 1:S1-27.
    View in: PubMed
    Score: 0.004
  166. VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids. PLoS One. 2013; 8(2):e57571.
    View in: PubMed
    Score: 0.004
  167. The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocr Pract. 2013 Jan-Feb; 19(1):107-16.
    View in: PubMed
    Score: 0.004
  168. In response. Endocr Pract. 2013 Jan-Feb; 19(1):170.
    View in: PubMed
    Score: 0.004
  169. Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations. PLoS One. 2012; 7(12):e50198.
    View in: PubMed
    Score: 0.004
  170. Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS One. 2012; 7(11):e48852.
    View in: PubMed
    Score: 0.004
  171. Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction. Metab Syndr Relat Disord. 2012 Aug; 10(4):244-51.
    View in: PubMed
    Score: 0.004
  172. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes. 1992 Apr; 41(4):465-75.
    View in: PubMed
    Score: 0.004
  173. Glucose transport and NIDDM. Diabetes Care. 1992 Mar; 15(3):396-417.
    View in: PubMed
    Score: 0.004
  174. Noggin is novel inducer of mesenchymal stem cell adipogenesis: implications for bone health and obesity. J Biol Chem. 2012 Apr 06; 287(15):12241-9.
    View in: PubMed
    Score: 0.004
  175. Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Atherosclerosis. 2012 Mar; 221(1):66-75.
    View in: PubMed
    Score: 0.004
  176. A clustering analysis of lipoprotein diameters in the metabolic syndrome. Lipids Health Dis. 2011 Dec 19; 10:237.
    View in: PubMed
    Score: 0.004
  177. Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2012 Jan; 14(1):40-6.
    View in: PubMed
    Score: 0.004
  178. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012 Feb; 20(2):330-42.
    View in: PubMed
    Score: 0.004
  179. Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS. Lipids Health Dis. 2011 Aug 19; 10:143.
    View in: PubMed
    Score: 0.004
  180. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest. 1991 Mar; 87(3):1072-81.
    View in: PubMed
    Score: 0.004
  181. Dietary adherence during weight loss predicts weight regain. Obesity (Silver Spring). 2011 Jun; 19(6):1177-81.
    View in: PubMed
    Score: 0.003
  182. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One. 2010 Dec 10; 5(12):e15234.
    View in: PubMed
    Score: 0.003
  183. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes. Endocr Pract. 2010 Jul-Aug; 16(4):629-40.
    View in: PubMed
    Score: 0.003
  184. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study. Endocr Pract. 2010 Jul-Aug; 16(4):617-28.
    View in: PubMed
    Score: 0.003
  185. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther. 2010 Jun; 12(6):419-25.
    View in: PubMed
    Score: 0.003
  186. Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes. 2010 Apr; 59(4):791-9.
    View in: PubMed
    Score: 0.003
  187. Insulin resistance and noninsulin-dependent diabetes mellitus: which horse is pulling the cart? Diabetes Metab Rev. 1989 Dec; 5(8):727-42.
    View in: PubMed
    Score: 0.003
  188. Entero-insular axis and postprandial insulin differences in African American and European American children. Am J Clin Nutr. 2008 Nov; 88(5):1277-83.
    View in: PubMed
    Score: 0.003
  189. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008 Oct; 14(7):933-46.
    View in: PubMed
    Score: 0.003
  190. Correlation of in vivo and in vitro actions of insulin in obesity and noninsulin-dependent diabetes mellitus: role of the glucose transport system. Diabetes Metab Rev. 1988 Sep; 4(6):543-69.
    View in: PubMed
    Score: 0.003
  191. Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes. Nutrition. 2008 Oct; 24(10):990-7.
    View in: PubMed
    Score: 0.003
  192. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008 Oct; 31(10):2006-12.
    View in: PubMed
    Score: 0.003
  193. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion. Diabetes. 1988 May; 37(5):590-9.
    View in: PubMed
    Score: 0.003
  194. Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest. 1988 May; 81(5):1528-36.
    View in: PubMed
    Score: 0.003
  195. Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis. 2009 Jan; 202(1):152-61.
    View in: PubMed
    Score: 0.003
  196. Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. J Diabetes Complications. 2008 May-Jun; 22(3):153-63.
    View in: PubMed
    Score: 0.003
  197. Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia. J Psychiatr Res. 2008 Oct; 42(13):1076-85.
    View in: PubMed
    Score: 0.003
  198. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness. Diabet Med. 2006 Sep; 23(9):955-66.
    View in: PubMed
    Score: 0.003
  199. Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes. 1986 Mar; 35(3):258-67.
    View in: PubMed
    Score: 0.003
  200. Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction. Biochemistry. 2006 Jan 31; 45(4):1128-37.
    View in: PubMed
    Score: 0.002
  201. Mitochondrial DNA genetic diversity among four ethnic groups in Sierra Leone. Am J Phys Anthropol. 2005 Sep; 128(1):156-63.
    View in: PubMed
    Score: 0.002
  202. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes. 1985 Mar; 34(3):222-34.
    View in: PubMed
    Score: 0.002
  203. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus. J Clin Endocrinol Metab. 1985 Mar; 60(3):559-68.
    View in: PubMed
    Score: 0.002
  204. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complications. 2005 Jan-Feb; 19(1):18-25.
    View in: PubMed
    Score: 0.002
  205. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses. Metabolism. 2004 Oct; 53(10):1296-304.
    View in: PubMed
    Score: 0.002
  206. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci. 2004 Mar; 45(3):910-8.
    View in: PubMed
    Score: 0.002
  207. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int. 2003 Sep; 64(3):817-28.
    View in: PubMed
    Score: 0.002
  208. Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes. 2003 May; 52(5):1215-21.
    View in: PubMed
    Score: 0.002
  209. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care. 2003 May; 26(5):1439-48.
    View in: PubMed
    Score: 0.002
  210. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care. 2003 Mar; 26(3):810-8.
    View in: PubMed
    Score: 0.002
  211. A role for the Agouti-Related Protein promoter in obesity and type 2 diabetes. Biochem Biophys Res Commun. 2001 Sep 21; 287(2):568-73.
    View in: PubMed
    Score: 0.002
  212. Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. Am J Phys Anthropol. 2001 Jan; 114(1):18-29.
    View in: PubMed
    Score: 0.002
  213. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000; 10(1):17-23.
    View in: PubMed
    Score: 0.002
  214. Endogenous mutations in human uncoupling protein 3 alter its functional properties. FEBS Lett. 1999 Dec 31; 464(3):189-93.
    View in: PubMed
    Score: 0.002
  215. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care. 1999 Aug; 22(8):1310-7.
    View in: PubMed
    Score: 0.002
  216. Diabetes research in South Carolina: past, present, and future. J S C Med Assoc. 1998 Nov; 94(11):502-8.
    View in: PubMed
    Score: 0.002
  217. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet. 1998 Oct; 63(4):1130-8.
    View in: PubMed
    Score: 0.001
  218. An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest. 1998 Apr 15; 101(8):1757-64.
    View in: PubMed
    Score: 0.001
  219. Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet. 1998 Mar; 62(3):659-68.
    View in: PubMed
    Score: 0.001
  220. Identification of Rad's effector-binding domain, intracellular localization, and analysis of expression in Pima Indians. J Cell Biochem. 1997 Jun 15; 65(4):527-41.
    View in: PubMed
    Score: 0.001
  221. Multiple endocrinopathies in an infant with fatal neurodegenerative disease. Am J Med Genet. 1997 Mar 31; 69(3):271-9.
    View in: PubMed
    Score: 0.001
  222. Genomewide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. Pima Diabetes Gene Group. Am J Hum Genet. 1997 Jan; 60(1):166-73.
    View in: PubMed
    Score: 0.001
  223. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest. 1996 Feb 15; 97(4):1111-6.
    View in: PubMed
    Score: 0.001
  224. Gene expression of epithelial glucose transporters: the role of diabetes mellitus. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S29-36.
    View in: PubMed
    Score: 0.001
  225. Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles. J Clin Endocrinol Metab. 1993 Jul; 77(1):286-9.
    View in: PubMed
    Score: 0.001
  226. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. FASEB J. 1991 Dec; 5(15):3031-6.
    View in: PubMed
    Score: 0.001
  227. Demonstration of a 1,25-dihydroxyvitamin D3-responsive protein in human lymphocytes: immunologic crossreactivity and inverse regulation with the vitamin D receptor. Proc Natl Acad Sci U S A. 1991 Oct 01; 88(19):8347-51.
    View in: PubMed
    Score: 0.001
  228. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med. 1988 Nov 28; 85(5A):86-105.
    View in: PubMed
    Score: 0.001
  229. Human adipocyte glucose transport system. Biochemical and functional heterogeneity of hexose carriers. J Clin Invest. 1987 Mar; 79(3):703-9.
    View in: PubMed
    Score: 0.001
  230. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus. Adv Exp Med Biol. 1985; 189:176-205.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.